Effect of the water-soluble and non-dialyzable fraction isolated from Senso (Chan Su) on lymphocyte proliferation and natural killer activity in C3H mice

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 2, 2004, Pages 256-260

  Shimizu, Yasuharu ^a   Inoue, Eiji ^a   Ito, Chihiro ^a  

^a Kyushin Pharmaceutical Co Ltd   (Japan)

Author keywords

Interleukin 12; Mitogenic activity; Natural killer activity; Senso; Toad venom

Indexed keywords

AGAROSE; CHINESE DRUG; CONCANAVALIN A; INTERLEUKIN 12; INTERLEUKIN 2; UNCLASSIFIED DRUG; BUFADIENOLIDE DERIVATIVE; IMMUNOLOGIC FACTOR; LECTIN; WATER;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CHAN SU; CONTROLLED STUDY; DRUG ISOLATION; DRUG PURIFICATION; IMMUNOPOTENTIATION; LYMPHOCYTE PROLIFERATION; MALE; MOLECULAR WEIGHT; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; SPLEEN CELL; SUPERNATANT; ANIMAL; C3H MOUSE; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; LYMPHOCYTE; METABOLISM; SOLUBILITY; SPLEEN;

ANIMALS; BUFANOLIDES; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; IMMUNOLOGIC FACTORS; INTERLEUKIN-12; INTERLEUKIN-2; KILLER CELLS, NATURAL; LECTINS; LYMPHOCYTES; MALE; MICE; MICE, INBRED C3H; SOLUBILITY; SPLEEN; WATER;

EID: 16544369324     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.256     Document Type: Article

References (19)

1. Suga T., Taisha, 10, 762-774 (1973).
2. Kamano Y., Kagaku No Ryoiki, 27, 984-1004 (1973).
3. Numazawa S., Shinoki M.-A., Ito H., Yoshida T., Kuroiwa Y., J. Cell Physiol., 160, 113-120 (1994).
4. Kamano Y., Yamashita A., Nogawa T., Morita H., Takeya K., Itokawa H., Segawa T., Yukita A., Saito K., Katsuyama M., Pettit G. R., J. Med. Chem., 45, 5440-5447 (2002).
5. Hayashi M., Rho M. C., Fukami A., Enomoto A., Nonaka S., Sekiguchi Y., Yanagisawa T., Yamashita A., Nogawa T., Kamano Y., Komiyama K., J. Pharmacol. Exp. Ther., 303, 104-109 (2002).
6. Matsubara T., Ueno M., Yokota Y., Kawasuji T., Saito H., Oyo Yakuri, 38, 71-78 (1989).
7. Matsubara T., Yokota Y., Ueno M., Kawasuji T., Saito H., J. Med. Pharm. Soc. (WAKAN-YAKU), 6, 75-83 (1989).
8. Clarke B. T., Biol. Rev., 72, 365-379 (1997).
9. Lai R., Liu H., Lee W.-H., Zang Y., Biochem. Biophys. Res. Commun., 295, 796-799 (2002).
10. Hata S., Osugi Y., "Pharmacological Screening for Development of New Drug," ed. by Ozawa H., Seishi-shoin, Tokyo, 1984, pp. 175-190.
11. Bradford M., Anal. Biochem., 72, 248-254 (1976).
12. Dubois M., Gilles K. A., Hamilton J. K., Rebers P. A., Smith F., Anal. Biochem., 28, 350 (1956).
13. Laemmli U. K., Nature (London), 227, 680-685 (1970).
14. Kodama N., Komuta K., Sakai N., Namba H., Biol. Pharm. Bull., 25, 1647-1650 (2002).
15. Mosmann T. R, Ann. N.Y. Acad. Sci., 664, 89-92 (1992).
16. Trinchieri G., Nat. Rev. Immunol., 3, 133-146 (2003).
17. Romagnani S., Allergy, 53 (Suppl. 46), 12-15 (1998).
18. Elsasser-Beile U., Kolbe N., Grussenmeyer T., Schultze-Seeman W., Wetterauer U., Gallati H., Schulte Monting J., von Kleist S., Tumour. Biol., 19, 470-476 (1998).
19. Lewis D. B., Curr. Opin. Immunol., 14, 644-651 (2002).